Quantcast
Last updated on April 20, 2014 at 5:20 EDT

The Oncology Nurse Community To Host Live Webinar On Fertility Preservation For Cancer Patients

December 11, 2012

NORWALK, Conn., Dec. 11, 2012 /PRNewswire/ — UBM Medica US announced that its online community for oncology nurses – TheONC.org – will host a webinar, “Fertility Preservation: Options for Patients with Cancer,” on Friday, December 14, 2012 at 12 p.m. ET. The webinar will address the effects of cancer treatment on fertility and outline options available for men and women to preserve fertility prior to treatment.

According to the American Cancer Society, about five percent of the more than 13.7 million cancer survivors in the United States are under the age of 40. Because cancer treatments such as surgery, radiation therapy, chemotherapy and hormonal therapy can affect fertility, concerns and options are important to address with patients before any treatment begins.

Key highlights of “Fertility Preservation” include:

  • A review of reproductive biology
  • Description of the effects of cancer treatment on fertility
  • Options for preserving fertility prior to cancer treatment
  • A discussion about the implications for oncology nursing practice

“Fertility Preservation: Options for Patients with Cancer” will be presented by Joanne Frankel Kelvin, RN, MSN, AOCN, a clinical nurse specialist from Memorial Sloan-Kettering Cancer Center.

Launched in February 2012, TheONC is a free, online community exclusively for oncology nurses and the cancer care teams that support them. TheONC unites nurses in a secure environment where they can leverage their collective knowledge, nurture professional growth, and emotionally support each other. Through shared experiences and access to free educational resources such as the melanoma webinar, members of TheONC can improve quality of life for themselves and quality of care for the patients they treat.

For more information, or to register for this free webinar, visit TheONC at www.TheONC.org.

TheONC is supported by an unrestricted grant from Bristol-Myers Squibb.

Media contact:
Amy Erdman
203-523-7041
amy.erdman@ubm.com

SOURCE UBM Medica US


Source: PR Newswire